Study Summary
This trial is testing the effects of diabetes and high/low blood sugar and insulin on the brain. You were chosen as a possible participant because you are either healthy or have diabetes.
- Type 1 Diabetes
- Healthy Subjects
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Baseline to 2 month
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
type 1 diabetes
1 of 2
healthy controls
1 of 2
Experimental Treatment
Non-Treatment Group
40 Total Participants · 2 Treatment Groups
Primary Treatment: hypoglycemia (low blood sugar) and MRI · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 65 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Minnesota | 100.0% |
What site did they apply to?
| University of Minnesota | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How responsive is this trial?
Typically responds via
| Phone Call | 100.0% |
Most responsive sites:
- University of Minnesota: < 48 hours
Average response time
- < 2 Days
Frequently Asked Questions
What is the participant limit for this experiment?
"Affirmative. According to clinicaltrials.gov, the research project that was initially published on October 31st 2019 is presently seeking participants. At this time, only 40 people are required for enrollment at 1 medical center with updates having been made as recently as February 9th 2022." - Anonymous Online Contributor
Does this study permit participation from individuals younger than fifty years of age?
"For eligibility, applicants must be aged 18 or older and below the age of 65." - Anonymous Online Contributor
Are individuals currently being recruited for this trial?
"Per clinicaltrials.gov, this experiment is seeking volunteers. It was initially listed on October 31st 2019 and modified most recently on February 9th 2022." - Anonymous Online Contributor
Is it possible for me to partake in this investigation?
"For this clinical trial, 40 individuals between the ages of 18-65 that have been diagnosed with type 1 diabetes mellitus are being enrolled. To be eligible for participation, patients must also demonstrate well-controlled blood sugar levels (HbA1c <7.5%) and meet additional healthy control criteria." - Anonymous Online Contributor